No Detail Found!

Role of Pitavastatin in Prevention of Osteopenic Changes in Ovariectomized Rats.

Author(s)
Farida Qadir Department of Pharmacology, Basic Medical Sciences Institute, Jinnah Postgraduate Medical Center, Karachi, Pakistan
Syed Mahboob Alam Department of Pharmacology, Basic Medical Sciences Institute, Jinnah Postgraduate Medical Center, Karachi, Pakistan
Tabassum Zehra Department of Pharmacology, Liaquat National Medical College, Stadium Road, Karachi, Pakistan
Ahmar Mehmood Medical Student, Dow International Medical College, Karachi, Pakistan
Abeer Qamar Siddiqi Sindh Medical College, Karachi, Pakistan
Abstract
Objective: To determine the effect of pitavastatin, a third generation statin, on development of osteopenia in ovariectomized rats. Study Design: Experimental study. Place and Duration of Study: Department of Pharmacology, Basic Medical Sciences Institute, Jinnah Postgraduate Medical Center, Karachi, from January to July 2013. Methodology: Forty female Sprague Dawley rats were divided into ovariectomized (OVX), Sham OVX and OVX given pitavastatin 0.4 mg/kg/day, 0.8 mg/kg/day, for 8 weeks. Bone density measurements using CT scan and Archimedes' principle were made on femora and tibiae. Blood samples were analyzed for acid phosphatase (ACP) and alkaline phosphatase (ALP) levels. Results: Ovariectomy-induced osteopenic changes were indicated by significant decrease in bone densities and Hounsfield (HU) index of distal femoral and proximal tibial metaphyses and elevation of ACP and ALP levels. 0.4 mg/kg pitavastatin did not significantly alter the evaluated parameters. 0.8 mg/kg produced a restoration of HU of lower femur and femoral density comparable to Sham. HU of upper tibia and tibial density following 0.8 mg/kg was significantly higher than OVX but was not approximate to Sham. ALP and ACP with 0.8 mg/kg were comparable to Sham. Conclusion: Supra-therapeutic dose of pitavastatin was effective in preventing estrogen deficiency-induced decrease in bone density of ovariectomized rates, over an 8-week period.
Publication Details
Page(s) 41-45
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 26, Issue: 1, Year: 2016

Request the full text from PASTIC

References
NationalOsteoporosis,Foundation., 2005.Fast facts on osteoporosis, -
DrakeMT,ClarkBL,KhoslaS.,Bisphosphonates, 2008.: mechanism of action and role in clinical practice,Mayo Clin Proc 83 1032 -45
StaalA,FrithJC,FrenchMH,SwartzJ,GüngörT,HarrityTW, 2003.The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-Co A reductase activity,J Bone Miner Res 18 88 -96
GarretR,MundyGR, 2002.Role of statins as potential targets for bone formation,Arthritis Res 4 237 -40
GarretIR,GutierrezG,MundyGR, 2001.Statins and bone formation,Curr Pharm Des 7 715 -36
MaritzFJ,ConradieMM,HulleyPA,GopalR, 2001.Effect of statins on bone mineral density and bone histomorphometry in rodents,Arterioscler Thromb Vasc Biol 21 1636 -41
YueJ,ZhangX,DongB,YangM. Statins, 2010.and bone strength in post-menopausal women: a systematic review of randomized controlled trials,Menopause 17 1071 -9
SmeethL,DouglasI,HallAJ,HubbardR,EvansS, 2009.Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials,Br J Clin Pharmacol 67 99 -109
SkolundB,AspenbergP, 2007.Locally applied simvastatin improves fracture healing in mice,BMC Musculoskelet Disord 27 80 -9
GarretIR,GutierrezGE,RossiniG,NymanJ,Mc CluskeyB,FloresA, 2007.Locally delivered lovastatin nanoparticles enhance fracture healing in rats,J Orthop Res 25 1351 -7
SugiyamaM,KodemaT,KonishiK,AbeK,AsamiS,OikawaS. Compactin, 2000.and simvastatin but not pravastatin induce bone morphogenetic protein-2 in human osteosarcoma cells,Biochem Biophys Res Comm 271 688 -92
ShannonRS,MinakshiN,NihalA, 2007.Dose translation from animal to human studies revisited,Faseb J 22 659 -61
SungBP,YoonJL,ChungKC, 2010.Bone mineral density changes after ovariectomy in rats as an osteopenic model: step-wise description of the double dorso-lateral approach,J Korean Neurosurg Soc 48 309 -12
BroulikPD,VondrovaJ,RuzickaP,SedlacekR,ZimaT., 2010.The effect of chronic alcohol administration on bone mineral content and bone strength in male rats,Physiol Res 59 599 -602
SchreiberJJ,AndersonPA,RosasHG,BuchholzAL,AuAG, 2011.Hounsfield units for assessing bone mineral density and strength: a tool for osteoporosis management,J Bone Joint Surg Am 93 1057 -63
AmmannP,RizzoliR,SlosmanD,BonjourJP, 1992.Sequential and precise in vivo measurement of bone mineral density in rats using dual-energy X-ray absorptiometry,J Bone Miner Res 7 311 -6
PajamäkiI,SievänenH,KannusP,JokihaaraJ,VuohelainenT,JärvinenTLN, 2008.Skeletal effects of estrogen and mechanical loading are structurally different,Bone 43 748 -57
OzturkF,BabacanH,GumusC., 2012.Effects of zalendronic acid on sutural bone formation: a computed tomography study,Eur J Orthod 34 141 -6
KeenanMJ,HegstedM,JonesKL,DelanyJP,KimeJC,MelanconLE, 1997.Comparison of bone density measurement techniques: DXA and archimedes' principle,J Bone Miner Res 12 1903 -7
RahnamaM,SwiatkowskiW., 2002.Effect of ovariectomy on biochemical markers of bone turnover (ALP, ACP) and calcium content in rat mandible and teeth,Bull Vet Inst Pulaway 46 281 -7
WronskiTJ,WalshCC,IgnaszewskiLA, 1986.Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats,Bone 7 119 -23
WronskiTJ,CintronM,DannLM, 1988.Temporal relationship between bone loss and increased bone turnover in ovariectomized rats,Calcif Tissue Int 43 179 -83
PytlikM,JanecW,MyrtaMM,GubalaI, 2003.Effect of simvastatin on development of osteopenia caused by ovariectomy in rats,Pol J Pharmacol 55 63 -71
GutierrezGE,EdwardsJR,GarrettIR,NymanJS,McCluskeyB,RossiniG, 2008.Transdermal lovastatin enhances fracture repair in rats,J Bone Miner Res 23 1722 -30
0

Citations

0

Downloads

55

Views